Show simple item record

dc.contributor.authorKiire, C.F.
dc.contributor.authorGombe-Mbalawa, C.
dc.contributor.authorTsega, E.
dc.contributor.authorLuande, J.
dc.contributor.authorMenenses, L.V.
dc.contributor.authorOkoth, J.
dc.contributor.authorOlweny, C.L.M.
dc.contributor.authorHolland, J.
dc.coverage.spatialAfrica.en
dc.date.accessioned2016-07-01T15:02:37Z
dc.date.available2016-07-01T15:02:37Z
dc.date.issued1992-11
dc.identifier.citationKiire, C.F. et al., (1992) Multicentre study of the treatment of primary liver cancer in Africa with two anthracycline drugs, Central African Journal of Medicine, vol. 38, no. 11, pp. 428-431. Harare: CAJM.en
dc.identifier.issn0008-9176
dc.identifier.urihttps://opendocs.ids.ac.uk/opendocs/handle/20.500.12413/12045
dc.descriptionA study of the treatment of primary liver cancer in tropical Africa.en
dc.description.abstractHepatocellular carcinoma (HCC) is among the twelve commonest cancers affecting mankind. In tropical Africa HCC is the most common malignant tumor, particularly among men. In Kyadondo County of Uganda the incidence rate is 5,1 cases per 100 000 men. In Nigeria the figure quoted for both sexes is 5,9 per 100 000 population. In Zimbabwe the incidence among the Black population is 20,8 per 100 000, while in Mozambique the figure is 103,8 per 100 000 males. These figures are in contradiction to what is observed in Europe and North America. In England HCC occurs in 2,5 per 100 000, while in North America it is seen in 1,8 per 100 000.en
dc.language.isoenen
dc.publisherFaculty of Medicine, Central African Journal of Medicine (CAJM), University College of Rhodesia (now University of Zimbabwe)en
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/en
dc.subjectHealthen
dc.titleMulticentre study of the treatment of primary liver cancer in Africa with two anthracycline drugsen
dc.typeArticleen
dc.rights.holderUniversity of Zimbabwe (UZ), Faculty of Medicine.en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc-nd/3.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-nd/3.0/